These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31900968)

  • 21. Atypical and secondary hemolytic uremic syndromes have a distinct presentation and no common genetic risk factors.
    Le Clech A; Simon-Tillaux N; Provôt F; Delmas Y; Vieira-Martins P; Limou S; Halimi JM; Le Quintrec M; Lebourg L; Grangé S; Karras A; Ribes D; Jourde-Chiche N; Rondeau E; Frémeaux-Bacchi V; Fakhouri F
    Kidney Int; 2019 Jun; 95(6):1443-1452. PubMed ID: 30982675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Where are we with haemolytic uremic syndrome?
    Cavero T; Alonso M
    Med Clin (Barc); 2018 Oct; 151(8):329-335. PubMed ID: 29699703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. First-line therapy in atypical hemolytic uremic syndrome: consideration on infants with a poor prognosis.
    Szarvas N; Szilágyi Á; Tasic V; Nushi-Stavileci V; Sofijanova A; Gucev Z; Szabó M; Szabó A; Szeifert L; Reusz G; Rusai K; Arbeiter K; Müller T; Prohászka Z
    Ital J Pediatr; 2014 Dec; 40():101. PubMed ID: 25496981
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromosomal rearrangement-A rare cause of complement factor I associated atypical haemolytic uraemic syndrome.
    Gleeson PJ; Wilson V; Cox TE; Sharma SD; Smith-Jackson K; Strain L; Lappin D; McHale T; Kavanagh D; Goodship TH
    Immunobiology; 2016 Oct; 221(10):1124-30. PubMed ID: 27268256
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Eculizumab Modifies Outcomes in Adults with Atypical Hemolytic Uremic Syndrome with Acute Kidney Injury.
    Cao M; Leite BN; Ferreiro T; Calvo M; Fernández C; Alonso Á; Rodriguez A; Salvador P; Seijo R; Pita S; Arjona E; Rodríguez de Córdoba S; Valdés Cañedo F
    Am J Nephrol; 2018; 48(3):225-233. PubMed ID: 30205388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report.
    Sevinc M; Basturk T; Sahutoglu T; Sakaci T; Koc Y; Ahbap E; Akgol C; Kara E; Brocklebank V; Goodship TH; Kavanagh D; Unsal A
    J Med Case Rep; 2015 Apr; 9():92. PubMed ID: 25925370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eculizumab in an anephric patient with atypical haemolytic uraemic syndrome and advanced vascular lesions.
    Békássy ZD; Kristoffersson AC; Cronqvist M; Roumenina LT; Rybkine T; Vergoz L; Hue C; Fremeaux-Bacchi V; Karpman D
    Nephrol Dial Transplant; 2013 Nov; 28(11):2899-907. PubMed ID: 24009284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement Factor I Variants in Complement-Mediated Renal Diseases.
    Zhang Y; Goodfellow RX; Ghiringhelli Borsa N; Dunlop HC; Presti SA; Meyer NC; Shao D; Roberts SM; Jones MB; Pitcher GR; Taylor AO; Nester CM; Smith RJH
    Front Immunol; 2022; 13():866330. PubMed ID: 35619721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Maternal and Fetal Outcomes of Pregnancies in Women with Atypical Hemolytic Uremic Syndrome.
    Gaggl M; Aigner C; Csuka D; Szilágyi Á; Prohászka Z; Kain R; Haninger N; Knechtelsdorfer M; Sunder-Plassmann R; Sunder-Plassmann G; Schmidt A
    J Am Soc Nephrol; 2018 Mar; 29(3):1020-1029. PubMed ID: 29282226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atypical haemolytic uremic syndrome secondary to acute pancreatitis: a unique presentation.
    Barish J; Kopparthy P; Fletcher B
    BMJ Case Rep; 2019 Sep; 12(9):. PubMed ID: 31519719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis and outcomes of atypical haemolytic uraemic syndrome in Czech children.
    Štolbová Š; Bezdíčka M; Seeman T; Prohászka Z; Csuka D; Hrachovinová I; Burkert J; Šimánková N; Průhová Š; Zieg J
    Eur J Pediatr; 2020 Nov; 179(11):1739-1750. PubMed ID: 32424742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case Report and Literature Review of Eculizumab Withdrawal in Atypical Hemolytic-Uremic Syndrome.
    Quiroga B; de Lorenzo A; Vega C; de Alvaro F
    Am J Case Rep; 2016 Dec; 17():950-956. PubMed ID: 27974740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Irreversible severe kidney injury and anuria in a 3-month-old girl with atypical haemolytic uraemic syndrome under administration of eculizumab.
    Okuda Y; Ishikura K; Terano C; Harada R; Hamada R; Hataya H; Ogata K; Honda M
    Nephrology (Carlton); 2016 Mar; 21(3):261-5. PubMed ID: 26818219
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atypical Hemolytic-Uremic Syndrome: An Update on Pathophysiology, Diagnosis, and Treatment.
    Raina R; Krishnappa V; Blaha T; Kann T; Hein W; Burke L; Bagga A
    Ther Apher Dial; 2019 Feb; 23(1):4-21. PubMed ID: 30294946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of Eculizumab in Atypical Hemolytic Uremic Syndrome, Complicating Systemic Lupus Erythematosus.
    Bermea RS; Sharma N; Cohen K; Liarski VM
    J Clin Rheumatol; 2016 Sep; 22(6):320-3. PubMed ID: 27556240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Living Donor Kidney Transplantation in Atypical Hemolytic Uremic Syndrome: A Case Series.
    Duineveld C; Verhave JC; Berger SP; van de Kar NCAJ; Wetzels JFM
    Am J Kidney Dis; 2017 Dec; 70(6):770-777. PubMed ID: 28821363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in CFI in a Japanese Patient: A Case Report.
    Osawa K; Yamamoto S; Yamano Y; Kita A; Okamoto K; Kato N; Tatematsu Y; Kojima F; Ohya M; Hara S; Murata SI; Inoue N; Maruyama S; Araki SI
    Intern Med; 2024 Jun; 63(12):1777-1782. PubMed ID: 37926536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful kidney transplant with eculizumab, thymoglobulin and belatacept therapy in a highly-sensitised patient with atypical haemolytic uraemic syndrome due to factor H mutation.
    Nieto-Ríos JF; Zuluaga-Quintero M; Bello-Márquez DC; Aristizabal-Alzate A; Ocampo-Kohn C; Serna-Higuita LM; Arias L; Zuluaga-Valencia G
    Nefrologia (Engl Ed); 2018; 38(4):433-437. PubMed ID: 29778558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Three months interval therapy of Eculizumab in a patient with atypical hemolytic uremic syndrome with hybrid CFHR1/CFH gene.
    Alobaidi S; AlDabbagh A; Alamoudi A; Almowarey M; Akl A
    CEN Case Rep; 2019 May; 8(2):139-143. PubMed ID: 30715674
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N; Szilágyi Á; Csuka D; Takács B; Rusai K; Müller T; Arbeiter K; Réti M; Haris Á; Wagner L; Török S; Kelen K; Szabó AJ; Reusz GS; Morgan BP; Prohászka Z
    Mol Immunol; 2016 Mar; 71():10-22. PubMed ID: 26826462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.